MetLife Investment Management, LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 162 filers reported holding CARA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$57,039
-42.4%
20,1550.0%0.00%
-100.0%
Q1 2023$98,962
-65.6%
20,155
-24.7%
0.00%
-50.0%
Q4 2022$287,628
+14.7%
26,7810.0%0.00%0.0%
Q3 2022$250,670
+16.4%
26,781
+13.5%
0.00%0.0%
Q2 2022$215,377
-35.0%
23,590
-13.5%
0.00%0.0%
Q1 2022$331,440
+49.4%
27,279
+49.8%
0.00%0.0%
Q4 2021$221,786
-21.2%
18,2090.0%0.00%
-33.3%
Q3 2021$281,329
+8.3%
18,2090.0%0.00%
+50.0%
Q2 2021$259,842
-34.3%
18,2090.0%0.00%
-50.0%
Q1 2021$395,317
+43.5%
18,2090.0%0.00%
+33.3%
Q4 2020$275,502
+18.9%
18,2090.0%0.00%0.0%
Q3 2020$231,710
-25.6%
18,2090.0%0.00%
-25.0%
Q2 2020$311,374
+29.4%
18,2090.0%0.00%
+33.3%
Q1 2020$240,541
-18.0%
18,2090.0%0.00%0.0%
Q4 2019$293,347
-11.9%
18,2090.0%0.00%
-25.0%
Q3 2019$332,861
-1.3%
18,209
+16.1%
0.00%0.0%
Q2 2019$337,163
+9.6%
15,6820.0%0.00%
+33.3%
Q1 2019$307,681
+50.9%
15,6820.0%0.00%0.0%
Q4 2018$203,866
-7.3%
15,682
+36.7%
0.00%0.0%
Q2 2018$220,000
+54.9%
11,4680.0%0.00%
+50.0%
Q1 2018$142,000
+1.4%
11,4680.0%0.00%0.0%
Q4 2017$140,00011,4680.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,568,057$70,005,00074.08%
Chescapmanager LLC 1,203,055$23,604,0002.80%
Mesirow Financial Investment Management, Inc. 29,821$585,0002.32%
DAFNA Capital Management LLC 143,611$2,818,0001.22%
Opaleye Management Inc. 200,000$3,924,0001.09%
SPHERA FUNDS MANAGEMENT LTD. 303,930$5,963,0000.54%
DISCIPLINED GROWTH INVESTORS INC /MN 852,892$16,734,0000.29%
DLD Asset Management, LP 352,700$6,927,0000.26%
SHANDA ASSET MANAGEMENT HOLDINGS Ltd 54,984$1,079,0000.18%
B. Riley Wealth Management, Inc. 33,755$662,0000.12%
View complete list of CARA THERAPEUTICS INC shareholders